A detailed history of Crews Bank & Trust transactions in Astrazeneca PLC stock. As of the latest transaction made, Crews Bank & Trust holds 836 shares of AZN stock, worth $57,349. This represents 0.01% of its overall portfolio holdings.

Number of Shares
836
Holding current value
$57,349
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 23, 2025

BUY
$63.2 - $79.58 $52,835 - $66,528
836 New
836 $54.8 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $213B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Crews Bank & Trust Portfolio

Follow Crews Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crews Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Crews Bank & Trust with notifications on news.